Davenport & CO LLC Cognition Therapeutics Inc Transaction History
Davenport & CO LLC
- $17.6 Billion
- Q4 2025
A detailed history of Davenport & CO LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Davenport & CO LLC holds 2,871,836 shares of CGTX stock, worth $4.45 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,871,836
Previous 2,689,336
6.79%
Holding current value
$4.45 Million
Previous $3.6 Million
23.54%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CGTX
# of Institutions
77Shares Held
23MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$9.3 Million9.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$4.16 Million0.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$3.42 Million0.02% of portfolio
-
Tang Capital Management LLC San Diego, CA1.2MShares$1.86 Million0.07% of portfolio
-
Chescapmanager LLC Baltimore, MD997KShares$1.55 Million0.14% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $35.2M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...